|
CTL peptides pools used in this study |
|||
| Pool |
Peptides |
5-PC* |
Peptide Sequences |
|
|
|||
| #1 |
25 |
55 |
Those shown in Table 1 |
| #2 |
15 |
13 |
FPVRPQVPL, KIQNFRVYY, AVFIHNFKR, GPKVKQWPL, LVGPTPVNI, TLNAWVKVI, GLNKIVRMY, TLFCASDAK, VIYQYMDDL, PLVKLWYQL, SPRTLNAWV, YVDRFFKTL, YFPDWQNYT, RAIEAQQHL, FVNTPPLVK |
| #3 |
13 |
11 |
FPVRPQVPL, KIQNFRVYY, AVFIHNFKR, GPKVKQWPL, LVGPTPVNI, TLNAWVKVI, GLNKIVRMY, TLFCASDAK, VIYQYMDDL, PLVKLWYQL, SPRTLNAWV, YVDRFFKTL, YFPDWQNYT |
| #4 |
11 |
5 |
FPVRPQVPL, KIQNFRVYY, AVFIHNFKR, GPKVKQWPL, LVGPTPVNI, TLNAWVKVI, GLNKIVRMY, TLFCASDAK, VIYQYMDDL, PLVKLWYQL, SPRTLNAWV |
| #5 |
7 |
2 |
FPVRPQVPL, KIQNFRVYY, AVFIHNFKR, GPKVKQWPL, LVGPTPVNI, TLNAWVKVI, GLNKIVRMY |
|
*5-PC: distinct 5-peptide combinations in the peptide pool each providing ≥ 95% PPC | |||
Reche et al. Medical Immunology 2006 5:1 doi:10.1186/1476-9433-5-1 |
|||